Reduced critical concentration might not have improved MGIT-based DST's sensitivity to rifampicin

Affiliations

• ¹ Unit of Mycobacteriology, Institute of Tropical Medicine, Antwerp, Belgium.
• ² Department of Biomedical Sciences, University of Antwerp, Wilrijk, Antwerp, Belgium.
• ³ The Indus Hospital laboratory, Karachi, Pakistan.
• ⁴ Socios en Salud, Lima, Peru.
• ⁵ Department of Microbiology, Sir JJ Hospital, Mumbai, India.
• ⁶ National Tuberculosis Reference Lab, Almaty, Kazakhstan.
• ⁷ Center for Tuberculosis, National Institute of Communicable Diseases, Mohakhali, South Africa.
• ⁸ Regional Tuberculosis Reference Lab, Ho Chi Minh, Vietnam.
• ⁹ National Tuberculosis Reference Lab, Hanoi, Vietnam.
• ¹⁰ Medical Department, MSF, Paris, France.
• ¹¹ Sorbonne University, Centre d'Immunologie et des Maladies Infectieuses (Cimi-Paris), Paris, France.
• ¹² AP-HP, Bactériologie-Hygiène, Hôpital Pitié-Salpêtrière, Centre National de Référence des Mycobactéries, Paris, France.
• ¹³ Brigham and Women's Hospital, Boston, Massachusetts, USA.
• ¹⁴ Partners In Health, Boston, Massachusetts, USA.
• ¹⁵ Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.